Esophageal Cancer
Conditions
Interventions
Case series:None
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Histologically confirmed esophageal squamous carcinoma; 2. Receive standardized neoadjuvant immunochemotherapy (PD-1/PD-L1 inhibitors combined with platinum-based doublet chemotherapy); 3. Has complete baseline and at least one post-treatment CT scan; 4. Possess postoperative pathology reports and follow-up records; 5. Sign the informed consent form; 6. Complete radical surgical resection.
Exclusion criteria
Exclusion criteria: 1. Combine with other primary malignant tumors; 2. Treatment interrupted during neoadjuvant therapy due to disease progression or severe toxicity; 3. Imaging or pathological data is severely missing; 4. Follow-up period is less than 6 months with no definite death events.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main pathological relief, MPR;Area Under Curve; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pathological complete remission, pCR;Disease-free survival, DFS;Overall Survival, OS; | — |
Countries
China
Contacts
Public ContactJiang Ke
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed